Cationic polypeptide design for polyion complex-mediated mRNA delivery

Q4 Pharmacology, Toxicology and Pharmaceutics Drug Delivery System Pub Date : 2022-07-25 DOI:10.2745/dds.37.221
Mitsuru Naito, K. Miyata
{"title":"Cationic polypeptide design for polyion complex-mediated mRNA delivery","authors":"Mitsuru Naito, K. Miyata","doi":"10.2745/dds.37.221","DOIUrl":null,"url":null,"abstract":"Recently, with the success of the COVID-19 vaccine, mRNA therapeutics have received a great deal of attention as a next-generation biopharmaceutical. One of the current key issues in mRNA therapeutics is the development of delivery vehicles with higher safety and targetability, excepting the liver. Herein, we introduce a systematic design strategy of cationic polypeptides and their polyplexes for enhanced mRNA delivery. Indeed, a series of cationic polypeptides were synthesized by the aminolysis reaction of poly(β-benzyl-L-aspartate)with varying amine compounds. First, cationic polyaspartamide derivatives were developed for efficient endosomal escape(or endosomal membrane destabilization)by highlighting the acidic pH-sensitivity of aminoethylene(-NHCH2 CH2-)units. Notably, a polyaspartamide derivative(PAsp(DET)) bearing diethylenetriamine(DET)moieties allowed efficient endosomal escape of polyplexes with lowered cytotoxicity. Second, varying hydrophobic moieties were introduced into the side chains of polyaspartamide derivative with the DET moieties to enhance the stability of mRNA-loaded polyplexes. The results indicated that the derivatives with a hydrophobicity index(or logD) > –2.4 elicited efficient mRNA transfection in cultured cells. As a result, a polyaspartamide derivative(PAsp(DET/CHE))with DET and cyclohexylethyl(CHE)moieties achieved the most efficient mRNA transfection without marked cytotoxicity, allowing the topical mRNA delivery in the ventricle via intracranial/intrathecal administration and the systemic mRNA delivery into the lung via intravenous administration. Third, self-catalytic degradation of cationic polyaspartamide derivatives was investigated by slightly changing the spacer length in the side chains. The main-chain degradation was substantially affected by the spacer length;the loss of one methylene spacer resulted in the 5-fold higher degradation rate. A polyaspartamide derivative(PAsp(EDA)) bearing the shorter spacer showed higher mRNA transfection efficiency in cultured cells with reduced cytotoxicity with an increase in pre-incubation time, compared with those bearing the longer spacers. Altogether, it is demonstrated that the polyplex-mediated mRNA delivery can be dramatically improved by fine-tuning the chemical structure of cationic polypeptides. © 2022, Japan Society of Drug Delivery System. All rights reserved.","PeriodicalId":11331,"journal":{"name":"Drug Delivery System","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Delivery System","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2745/dds.37.221","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Recently, with the success of the COVID-19 vaccine, mRNA therapeutics have received a great deal of attention as a next-generation biopharmaceutical. One of the current key issues in mRNA therapeutics is the development of delivery vehicles with higher safety and targetability, excepting the liver. Herein, we introduce a systematic design strategy of cationic polypeptides and their polyplexes for enhanced mRNA delivery. Indeed, a series of cationic polypeptides were synthesized by the aminolysis reaction of poly(β-benzyl-L-aspartate)with varying amine compounds. First, cationic polyaspartamide derivatives were developed for efficient endosomal escape(or endosomal membrane destabilization)by highlighting the acidic pH-sensitivity of aminoethylene(-NHCH2 CH2-)units. Notably, a polyaspartamide derivative(PAsp(DET)) bearing diethylenetriamine(DET)moieties allowed efficient endosomal escape of polyplexes with lowered cytotoxicity. Second, varying hydrophobic moieties were introduced into the side chains of polyaspartamide derivative with the DET moieties to enhance the stability of mRNA-loaded polyplexes. The results indicated that the derivatives with a hydrophobicity index(or logD) > –2.4 elicited efficient mRNA transfection in cultured cells. As a result, a polyaspartamide derivative(PAsp(DET/CHE))with DET and cyclohexylethyl(CHE)moieties achieved the most efficient mRNA transfection without marked cytotoxicity, allowing the topical mRNA delivery in the ventricle via intracranial/intrathecal administration and the systemic mRNA delivery into the lung via intravenous administration. Third, self-catalytic degradation of cationic polyaspartamide derivatives was investigated by slightly changing the spacer length in the side chains. The main-chain degradation was substantially affected by the spacer length;the loss of one methylene spacer resulted in the 5-fold higher degradation rate. A polyaspartamide derivative(PAsp(EDA)) bearing the shorter spacer showed higher mRNA transfection efficiency in cultured cells with reduced cytotoxicity with an increase in pre-incubation time, compared with those bearing the longer spacers. Altogether, it is demonstrated that the polyplex-mediated mRNA delivery can be dramatically improved by fine-tuning the chemical structure of cationic polypeptides. © 2022, Japan Society of Drug Delivery System. All rights reserved.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
阳离子多肽设计用于聚离子复合物介导的信使核糖核酸递送
最近,随着新冠病毒疫苗的成功,mRNA治疗剂作为新一代生物制药备受关注。目前mRNA治疗的关键问题之一是开发具有更高安全性和靶向性的递送载体,肝脏除外。在此,我们介绍了一种系统的设计策略,阳离子多肽及其多聚体,以增强mRNA的传递。通过不同胺类化合物对聚β-苄- l-天冬氨酸的氨解反应,合成了一系列阳离子多肽。首先,通过强调氨基(- nhch2 - CH2-)单元的酸性ph敏感性,开发了阳离子聚天冬酰胺衍生物,用于有效的内体逃逸(或内体膜不稳定)。值得注意的是,含有二乙烯三胺(DET)部分的聚天冬酰胺衍生物(PAsp(DET))可以有效地使多聚体内体逃逸,降低细胞毒性。其次,在聚天冬酰胺衍生物的侧链中引入不同的疏水基团与DET基团,以提高mrna负载复合物的稳定性。结果表明,疏水指数(或logD)为> -2.4的衍生物可在培养细胞中高效转染mRNA。结果,聚天冬酰胺衍生物(PAsp(DET/CHE))具有DET和环己基乙基(CHE)部分,实现了最有效的mRNA转染,没有明显的细胞毒性,允许通过颅内/鞘内给药在脑室局部传递mRNA,并通过静脉给药在肺部全身传递mRNA。第三,通过改变侧链上的间隔长度,研究了阳离子聚阿斯巴胺衍生物的自催化降解。主链的降解主要受间隔段长度的影响,每减少一个亚甲基间隔段,降解率提高5倍。与具有较长间隔的细胞相比,具有较短间隔的聚阿斯巴胺衍生物(PAsp(EDA))在培养细胞中表现出更高的mRNA转染效率,并且随着预孵育时间的增加,细胞毒性降低。总之,研究表明,通过微调阳离子多肽的化学结构,可以显著改善多聚体介导的mRNA传递。©2022,日本药物输送系统协会。版权所有。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Drug Delivery System
Drug Delivery System Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
自引率
0.00%
发文量
26
期刊最新文献
CRS2023 ANNUAL MEETING & EXPOSITION シクロデキストリン超分子を用いたバイオ医薬品のためのユニバーサルキャリア Increased Target Cell Selectivity of Exosome Modified with Glycan Polymers Drug for Duchenne muscular dystrophy ViltepsoⓇ 第39回日本DDS学会学術集会
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1